Equifax Inc. director reports additional deferred stock-based compensation. A board member of Equifax Inc. (EFX), filing as a director and sole reporting person, recorded an acquisition of 156 phantom stock units on 12/31/2025 under the company’s Board of Directors Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Equifax common stock and represents fees that the director elected to receive in stock-based form instead of cash annual retainer payments. After this transaction, the director beneficially owns 2,284 phantom stock units held directly. These units are payable, at the director’s election, upon termination of service as a director, meaning the value tracks Equifax’s stock until that time but does not involve immediate cash or share delivery.
Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/20/2025, the executive sold 2,500 shares of Equifax common stock at a price of $208.37 per share in an open-market sale coded as "S." The filing notes that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on 5/14/2025, which is designed to systematically execute trades. Following this transaction, the executive beneficially owned 59,527 shares of Equifax common stock directly.
EFX has a planned insider sale disclosed on Form 144. A person related to the company intends to sell 2,500 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of 520,925.00, on or around 11/20/2025 on the NYSE. The filing notes that there were 122,394,037 shares outstanding.
The shares to be sold were acquired on 02/23/2024 through restricted stock vesting from the issuer as compensation, and the full 2,500 shares acquired in that transaction are listed for sale. The form also includes a standard representation that the seller is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Equifax Inc. (EFX) executive reports tax-related share withholding. The company's EVP and Chief HR Officer filed a Form 4 disclosing that on 11/14/2025, 227 shares of Equifax common stock were withheld upon the early vesting of an equal number of restricted stock units to cover taxes associated with the executive becoming retirement eligible. The shares were valued at $204.86 each for this withholding transaction.
After this event, the executive beneficially owned 13,450 shares of Equifax common stock. This total includes accrued dividend equivalent units reinvested in corresponding restricted stock units through the company's last dividend payment date and 270 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan. The transaction reflects routine tax withholding rather than an open-market sale.
Equifax Inc. executive files Form 4 reporting tax withholding on vested stock units. The company's EVP and Chief Legal Officer reported that on 11/14/2025, 260 shares of Equifax common stock were withheld at a price of $204.86 per share to cover taxes due when an equal number of restricted stock units vested early as the executive became retirement eligible. After this withholding transaction, the reporting person beneficially owned 15,927 shares of Equifax common stock, which include dividend equivalent units that were reinvested in corresponding restricted stock units through the company's most recent dividend payment date.
Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/14/2025, 202 shares of common stock were withheld at a price of $204.86 per share to cover taxes due on the early vesting of an equal number of restricted stock units after the executive became retirement eligible. Following this tax withholding, the reporting person directly beneficially owns 62,027 shares, which include accrued dividend equivalent units from reinvested dividends.
The Vanguard Group filed Amendment No. 14 to Schedule 13G reporting a passive beneficial ownership stake in Equifax Inc. (EFX). Vanguard reported 15,282,951 shares beneficially owned, representing 12.34% of the class as of 09/30/2025.
Vanguard reported 0 shares with sole voting power and 731,561 shares with shared voting power. It disclosed 14,103,287 shares with sole dispositive power and 1,179,664 shares with shared dispositive power. Vanguard certified the securities were acquired and held in the ordinary course and not for the purpose of changing or influencing control. Vanguard noted its clients have the right to receive dividends or proceeds, and no one other person's interest exceeds 5%.
Equifax (EFX) CEO and director reported insider transactions on 10/27/2025. The reporting person exercised 27,959 stock options at $191.44 and executed multiple open‑market sales under a Rule 10b5‑1 trading plan adopted on 11/14/2024, plus a G code gift of 47 shares.
Sales included 6,943 shares at a weighted average price of $232.1887 and 6,639 shares at $230.184, among other tranches disclosed. Following the reported transactions, direct beneficial ownership was 142,934 shares. Indirect holdings in grantor retained annuity trusts (GRATs) remained, including 22,045 shares in the “2‑yr Jun 2025 GRAT” and 16,287 shares in the “3‑yr Jul 2024 GRAT.”
Equifax (EFX) reported an insider transaction by its EVP, Chief Technology Officer. On 10/27/2025, the officer exercised options for 4,925 shares of common stock at $175.48 per share (code M) and sold 4,925 shares at $238.94 (code S) pursuant to a Rule 10b5-1 trading plan adopted on 4/25/2025.
Following these transactions, the officer directly beneficially owned 39,364 shares. The option related to 4,925 underlying shares had an exercise price of $175.48 and an expiration of 02/21/2026, and vested in three equal annual increments beginning 2/21/2021. Holdings include accrued dividend equivalent units and shares acquired via the company’s 2020 Employee Stock Purchase Plan.
Equifax Inc. filed a Form 144 notice for a proposed sale of 49,345 common shares. The filing lists Fidelity Brokerage Services as broker and an aggregate market value of $11,404,110.96, with an approximate sale date of 10/27/2025 on the NYSE.
The shares to be sold reflect prior acquisitions: 21,386 shares from restricted stock vesting on 05/04/2021 (compensation) and 27,959 shares tied to an option granted on 02/21/2020, with cash payment dated 10/27/2025. Shares outstanding were 122,394,037; this is a baseline figure, not the amount being sold.
The filing also notes a sale during the prior three months: Mark W. Begor sold 48,264 common shares on 07/28/2025 for gross proceeds of $11,666,012.59.